申请人:Ono Pharmaceutical Co., Ltd.
公开号:US04310533A1
公开(公告)日:1982-01-12
The guanidinobenzoic acid derivatives of the general formula: ##STR1## wherein Z represents a carbon-carbon covalent bond, or a methylene, ethylene or vinylene group, R.sup.1 represents a hydrogen atom, or a straight- or branched-chain alkyl group containing from 1 to 4 carbon atoms, R.sup.2 represents a straight- or branched-chain alkyl group containing from 4 to 10 carbon atoms, or a cycloalkyl or cycloalkenyl or straight- or branched-chain alkenyl group containing from 3 to 8 carbon atoms, or a phenyl or benzyl group, or NR.sup.1 R.sup.2 represents a 4- to 8-membered heterocyclic ring, and acid addition salts thereof, have anti-plasmin and anti-trypsin activities.
通式为:##STR1##其中,Z代表碳-碳共价键,或亚甲基、乙烯基或乙烯基基团,R.sup.1代表氢原子,或含有1至4个碳原子的直链或支链烷基,R.sup.2代表含有4至10个碳原子的直链或支链烷基,或含有3至8个碳原子的环烷基、环烯基或直链或支链烯基,或苯基或苄基,或NR.sup.1R.sup.2代表4-至8-成员杂环环,以及它们的酸加成盐具有抗血浆酶和抗胰蛋白酶活性。